Literature DB >> 26526862

Vaccine recommendations for children and youth for the 2015/2016 influenza season.

Dorothy L Moore.   

Abstract

The Canadian Paediatric Society continues to encourage annual influenza vaccination for ALL children and youth ≥6 months of age. Recommendations from the National Advisory Committee on Immunization for the 2015/2016 influenza season include some important changes: Children and adolescents with neurological or neurodevelopmental disorders were added to the list of individuals considered to be at high risk for severe influenza.Quadrivalent influenza vaccines are recommended preferentially over trivalent vaccines for use in children and youth.An adjuvanted trivalent inactivated influenza vaccine is now available for use in children six to 23 months of age.

Entities:  

Keywords:  Children; IIV; Influenza vaccine; LAIV

Year:  2015        PMID: 26526862      PMCID: PMC4614095          DOI: 10.1093/pch/20.7.389

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  3 in total

1.  Vaccine recommendations for children and youth for the 2014/2015 influenza season.

Authors:  Dorothy L Moore
Journal:  Paediatr Child Health       Date:  2014-10       Impact factor: 2.253

2.  Burden of seasonal influenza in children with neurodevelopmental conditions.

Authors:  Catherine Burton; Wendy Vaudry; Dorothy Moore; Julie A Bettinger; Dat Tran; Scott A Halperin; David W Scheifele
Journal:  Pediatr Infect Dis J       Date:  2014-07       Impact factor: 2.129

3.  Influenza activity - United States, 2014-15 season and composition of the 2015-16 influenza vaccine.

Authors:  Grace D Appiah; Lenee Blanton; Tiffany D'Mello; Krista Kniss; Sophie Smith; Desiree Mustaquim; Craig Steffens; Rosaline Dhara; Jessica Cohen; Sandra S Chaves; Joseph Bresee; Teresa Wallis; Xiyan Xu; Anwar Isa Abd Elal; Larisa Gubareva; David E Wentworth; Jacqueline Katz; Daniel Jernigan; Lynnette Brammer
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-06-05       Impact factor: 17.586

  3 in total
  2 in total

Review 1.  Diagnosis and management of food allergy.

Authors:  Elissa M Abrams; Scott H Sicherer
Journal:  CMAJ       Date:  2016-09-06       Impact factor: 8.262

2.  MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial in Mexico.

Authors:  Aurelio Cruz-Valdez; Gabriel Valdez-Zapata; Sanjay S Patel; Flavia V Castelli; Marcia G Garcia; Wim T Jansen; Ashwani Kumar Arora; Esther Heijnen
Journal:  Hum Vaccin Immunother       Date:  2018-01-03       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.